Chimin Health Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 28, 2021 at 11:03 am EDT
Share
Chimin Health Management Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 253.770 million compared to CNY 131.807 million a year ago. Operating income was CNY 49.268 million compared to operating loss of CNY 13.799 million a year ago. Net income was CNY 39.943 million compared to net loss of CNY 7.307 million a year ago. Basic earnings per share from continuing operations was CNY 0.12 compared to basic loss per share from continuing operations of CNY 0.02 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
